Patient Recruitment Challenges in Respiratory Research
Respiratory diseases like COPD, asthma, pulmonary fibrosis, and sleep apnea remain among the most prevalent—and complex—conditions in clinical research. Despite strong therapeutic pipelines, pulmonology trials face some of the highest screen-failure rates and lowest show rates due to comorbidities, geographic dispersion, and patient fatigue.
Recruitment challenges include:
- Underdiagnosed populations and variable symptom onset
- Stringent inclusion criteria (spirometry, imaging, biomarkers)
- Diverse patient motivations—from ex-smokers in COPD studies to caregivers in pediatric asthma
- Compliance complexity around IRB-approved creative and health data protection
OMNI CRS transforms this process through data-driven precision outreach and compliance-backed recruitment speed.
Accelerating Pulmonology Enrollment
OMNI CRS accelerates your pulmonology trial enrollment through multi-channel performance marketing, predictive data analytics, and HIPAA/GCP-compliant processes.
As a trusted partner for sponsors, CROs, and research sites, OMNI combines high-precision targeting with compassionate, plain-language communication to reach and retain qualified respiratory patients. Our recruitment platform has delivered measurable success across 35+ therapeutic areas and 150+ indications, including large-scale respiratory studies.
Our Impact in Pulmonology and Respiratory Trials
Working with OmniCRS delivers measurable outcomes:
Proven experience across COPD, asthma, ILD/IPF, and sleep apnea trials
Data-verified pre-screening to reduce screen failures and increase match accuracy
832,000+ qualified leads generated across all therapeutic areas
Predictable enrollment pipelines for Phase II–III respiratory protocols
By merging data science, multilingual creative, and patient-centric outreach, OMNI has consistently delivered faster enrollment timelines and higher randomization rates—without compromising compliance or quality.
How OMNI CRS Delivers Exceptional Patient Enrollment
Multi-Channel Outreach
Geo-targeted digital campaigns, social engagement, provider referrals, and advocacy collaborations reach patients with conditions such as COPD, asthma, and ILD—wherever they are. Messaging frameworks are customized by audience (e.g., smokers/ex-smokers for COPD, parents for pediatric asthma, ILD advocacy for rare conditions).
Predictive Data & Pre-Screening
Automated pre-screening and real-time analytics enhance feasibility and forecast randomizations. OMNI integrates tele-pre-screening, ePRO capture, and hybrid logistics to expand reach and improve show rates.
Compliance & Transparency
We prioritize inclusion through multilingual creative and culturally aligned community outreach—ensuring equitable access for underrepresented populations. Every campaign meets HIPAA, IRB, and GCP standards, with IRB-reviewed workflows and transparent reporting.
Proprietary fraud-prevention • HIPAA / GDPR / FDA compliance • Continuous quality monitoring
Results That Advance Pulmonology Research
OMNI CRS consistently delivers 30–40% faster enrollment and up to 50% lower screen-failure rates through adaptive recruitment and feedback-driven optimization.
In recent respiratory campaigns, OMNI’s precision targeting and hybrid patient pathways have significantly improved show rates and reduced drop-offs—creating reliable, ready-to-randomize cohorts for sites.
Partner With OMNI CRS to Improve Pulmonology Trial Outcomes
Your pulmonology trial deserves a recruitment partner that brings speed, precision, and compliance to every campaign. OMNI CRS delivers reliable, scalable enrollment solutions trusted by CROs, pharma, and sites nationwide.